Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Teens staying in pediatric diabetes care until late adolescence may have a successful transition to adult care

Keeping adolescents with type 1 diabetes in pediatric diabetes care until at least age 17 may increase the chance that they will have a successful transition to adult care, according to a study presented Thursday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

15 Jun 2023

Managing blood sugar levels during exercise remains a challenge for people with type 1 diabetes

Many people with type 1 diabetes struggle to exercise safely while keeping their blood sugar levels within a healthy range, according to a study presented Thursday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

15 Jun 2023

Reinforcement learning significantly outperforms commercial blood glucose controllers

The same type of machine learning methods used to pilot self-driving cars and beat top chess players could help type-1 diabetes sufferers keep their blood glucose levels in a safe range.

15 Jun 2023

Maximizing the function and potential of stem cell-based treatments for patients with Type 1 diabetes

Following encouraging results from pre-clinical research and a recent clinical trial on stem cell-based treatments for patients with Type 1 diabetes, researchers are now working on maximizing the function and potential of stem cell-based treatments for future application in patients.

13 Jun 2023

The phenolic composition, antioxidant capacity, and other functional properties of fresh and dried figs

Researchers explored the phytochemical contents and health benefits of consuming figs.

6 Jun 2023

Is there radiographic evidence of premature brain aging in individuals with type 1 diabetes?

Researchers identified brain regions most affected in middle-aged and older adults with type I diabetes.

6 Jun 2023

Microparticle-delivered therapy likely to be the first step toward stopping autoimmune diseases

According to the federal government's National Institute of Neurological Disorders and Stroke, nearly 3 million people worldwide -; with almost a third in the United States -; are living with multiple sclerosis (MS), a disabling neurological disease in which the body's immune system mistakenly attacks nerves feeding information to the central nervous system (the brain and spinal cord). Although rarely fatal, MS can lead to long-term disabilities, and impair movement, muscle control, vision and cognition.

6 Jun 2023

Burden of autoimmune disease continues to increase over time, research suggests

EULAR – the European Alliance of Associations for Rheumatology – works on a broad spectrum of autoimmune and auto-inflammatory diseases.

31 May 2023

ENDO 2023 news conferences to highlight latest research in diabetes, obesity, reproductive health

Researchers will delve into the latest research in diabetes, obesity, reproductive health and other aspects of endocrinology during the Endocrine Society's ENDO 2023 news conferences June 15-18.

30 May 2023

Gene expression signature associated with rapid progression of type 1 diabetes

Researchers from Turku Bioscience Centre and InFLAMES Flagship at the University of Turku in Finland, have identified a gene expression signature that can predict the progression of type 1 diabetes.

29 May 2023

Do glucose-lowering medications have different effects on kidney outcomes?

Researchers evaluated the kidney outcomes in individuals with type 2 diabetes.

26 May 2023

Targeting stem cells from the human stomach for treating diabetes

Stem cells from the human stomach can be converted into cells that secrete insulin in response to rising blood sugar levels, offering a promising approach to treating diabetes, according to a preclinical study from researchers at Weill Cornell Medicine.

25 May 2023

This panel will decide whose medicine to make affordable. Its choice will be tricky.

Catherine Reitzel's multiple sclerosis medication costs nearly $100,000 a year. Kris Garcia relies on a drug for a blood-clotting disorder that runs $10,000 for a three-day supply. And Mariana Marquez-Farmer would likely die within days without her monthly $300 vial of insulin.

25 May 2023

SARS-CoV-2 infection linked to increased risk of type 1 diabetes in children

Different studies have documented an increased incidence of type 1 diabetes during the COVID-19 pandemic.

24 May 2023

Is COVID-19 diagnosis associated with the risk and incidence of type 1 diabetes?

Researchers assessed the incidence and risk of type 1 diabetes in children with coronavirus disease 2019.

24 May 2023

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

A bionic pancreas-;a wearable, pocket-sized, automated insulin delivery device-;that was first developed in a Boston University lab has been cleared by the US Food and Drug Administration (FDA). The iLet Bionic Pancreas is now commercially available, bringing fresh hope to the almost two million Americans with type 1 diabetes.

23 May 2023

Advances in automated insulin delivery systems reduce disease management burden for patients with diabetes

Type 1 diabetes affects 46.3 million people worldwide, and the number of people affected increases by about 3% each year.

23 May 2023

Toddler’s gut bacteria highly predictive of body mass index at age 5

The make-up and volume of gut bacteria in toddlers at 3.5 years old is predictive of body mass index (BMI) at age 5, irrespective of whether they are born prematurely or not, according to new research, being presented at this year's European Congress on Obesity (ECO) in Dublin, Ireland (17-20 May).

22 May 2023

Swedish research offers insights to improve the treatment of type 2 diabetes in India

Researchers at Lund University have shown that diabetes can be divided into five subgroups, and that there are genetic differences between the four subgroups relating to type 2 diabetes.

3 May 2023

Improving cancer treatment outcomes: the potential use of fermented food interventions

Researchers reviewed the use of fermented food interventions to alter the gut microbiome composition and improve immunotherapy.

25 Apr 2023

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Teens staying in pediatric diabetes care until late adolescence may have a successful transition to adult care

Managing blood sugar levels during exercise remains a challenge for people with type 1 diabetes

Reinforcement learning significantly outperforms commercial blood glucose controllers

Maximizing the function and potential of stem cell-based treatments for patients with Type 1 diabetes

The phenolic composition, antioxidant capacity, and other functional properties of fresh and dried figs

Is there radiographic evidence of premature brain aging in individuals with type 1 diabetes?

Microparticle-delivered therapy likely to be the first step toward stopping autoimmune diseases

Burden of autoimmune disease continues to increase over time, research suggests

ENDO 2023 news conferences to highlight latest research in diabetes, obesity, reproductive health

Gene expression signature associated with rapid progression of type 1 diabetes

Do glucose-lowering medications have different effects on kidney outcomes?

Targeting stem cells from the human stomach for treating diabetes

This panel will decide whose medicine to make affordable. Its choice will be tricky.

SARS-CoV-2 infection linked to increased risk of type 1 diabetes in children

Is COVID-19 diagnosis associated with the risk and incidence of type 1 diabetes?

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

Advances in automated insulin delivery systems reduce disease management burden for patients with diabetes

Toddler’s gut bacteria highly predictive of body mass index at age 5

Swedish research offers insights to improve the treatment of type 2 diabetes in India

Improving cancer treatment outcomes: the potential use of fermented food interventions

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in